Fund Management at Engine No 1’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-29,874
Closed -$1.73M 61
2023
Q3
$1.73M Buy
29,874
+2,523
+9% +$155K 0.27% 76
2023
Q2
$1.75M Buy
27,351
+1,563
+6% +$105K 0.32% 69
2023
Q1
$1.79M Buy
25,788
+2,381
+10% +$168K 0.36% 63
2022
Q4
$1.68M Buy
23,407
+2,875
+14% +$217K 0.41% 57
2022
Q3
$1.46M Sell
20,532
-964
-4% -$69.9K 0.43% 55
2022
Q2
$1.66M Buy
21,496
+3,043
+16% +$232K 0.44% 55
2022
Q1
$1.35M Buy
+18,453
New +$1.24M 0.34% 73

Other funds holding BMY

Fund Management at Engine No 1's BMY Position: Q4 2023 in Review

Fund Management at Engine No 1 sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 29,874 shares — an estimated $1.73M sold.

Fund Management at Engine No 1 first reported a position in BMY in Q1 2022 and held it in 7 quarters. The position peaked at $1.79M in Q1 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Fund Management at Engine No 1 reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Fund Management at Engine No 1 sold 29,874 Bristol-Myers Squibb shares in Q4 2023, an estimated $1.73M.
  • Fund Management at Engine No 1 first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 7 quarters.
  • Fund Management at Engine No 1's Bristol-Myers Squibb position peaked at $1.79M in Q1 2023.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Fund Management at Engine No 1's 13F filing for Q4 2023.